DM Healthcare

DM Healthcare Investment

News

February 9, 2024 - Humacyte's Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma

February 5th, 2024 - uLab® Receives Townie Choice Awards for its uSmile™ Clear Aligners and uAssist™ Aligner Treatment Planning Assistance Service

February 1st, 2024 - Asia Regenerative Medicine (Hong Kong) Limited Successfully Closes Seed Round

January 16th, 2024 - Convergence Biomanufacturing Ltd. Officially Opens New Office and Holds Conference with Top Biomanufacturing and Microfludics Professor from China and Hong Kong

January 11th, 2024 - Rege Nephro announces joint research agreement with CiRA Kyoto University and Abu Dhabi Stem Cells Center Aiming to develop new treatments for diabetes through collaborative research using iPS cells

December 27th, 2023 - Rege Nephro Announces Joint Research Agreement with CiRA-Kyoto University, Toyo Seikan Group Holdings, and Shimadzu Corporation Aiming to develop novel cell therapy that suppresses the progression of liver cirrhosis

December 12th, 2023 - Humacyte Submits Biologics License Application (BLA) to U.S. FDA Seeking Approval of Human Acellular Vessel™ (HAV™) for the Treatment of Vascular Trauma

December 11th, 2023 - Rege Nephro announces extension of joint research agreement with CiRA-Kyoto University and AstraZeneca Aiming to realize kidney regenerative medicine with a strong international team

December 4th, 2023 - Rege Nephro will soon begin a clinical trial for autosomal dominant polycystic kidney disease (ADPKD) discovered by our scientific founder, Professor Kenji Osafune

November 24th, 2023 - Broncus has announced the acquisition of the entire interest in Hangzhou Jingliang

November 1st, 2023 - uLab® Announces Smart Outcomes™ for a Smart Office™—The Power and Flexibility of One Platform for Clear Aligners and Retainers

October 30th, 2023 - United Therapeutics to Acquire Miromatrix Medical

October 16th, 2023 - Humacyte Publishes Preclinical Results Showing Human Acellular Vessel™ (HAV™) Patency as Modified Blalock–Taussig–Thomas Shunt in Juvenile Primate Model

September 18th, 2023 - Broncus Medical (02216.HK) announced long-term follow up data on InterVapor, showing stable long-term efficacy in patients

September 12th, 2023 - Humacyte announces positive top line results from Phase 2/3 trial of Human Acellular Vessel™ (HAV™) in treatment of patients with vascular trauma

August 15th, 2023 - Humacyte presents clinical performance of Human Acellular Vessel™ (HAV™) from Ukraine Humanitarian Program

August 14th, 2023 - Eli Lilly completes acquisition of Sigilon Therapeutics

August 7th, 2023 - 6-Month registered clinical trial data on world's first transbronchial pulmonary radiofrequency ablation system for lung cancer announced, showing significant efficacy (Broncus)

August 3rd, 2023 - Humacyte announces publication of biological mechanism explaining low rates of infection observed in clinical study of Human Acellular Vessel™ (HAV™)

July 31st, 2023 - Asia Regenerative Medicine, Hong Kong is selected as one of the Top 100 Teams in the 2023 Alibaba JUMPSTARTER competition

July 26th, 2023 - Humacyte completes enrollment in Phase 2/3 trial of Human Acellular Vessel™ (HAV™) for vascular trauma repair

July 13th, 2023 - Miromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement Award

July 10th, 2023 - Broncus completes the first case of registered clinical trials of its targeted lung denervation radiofrequency ablation system

June 30th, 2023 - Asia Regenerative Medicine Ltd. Successfully Completes Pre-A+ Round, Raises 12.2M USD

June 29th, 2023 - Eli Lilly to acquire Sigilon Therapeutics

June 28th, 2023 - uLab™ announces innovative, industry-first pricing structure optimizing orthodontic costs and flexibility

June 12th, 2023 - IVIVA Medical wins KidneyX prize for advanced organ therapeutics to cure renal failure

June 1st, 2023 - Asia Regenerative Medicine, Hong Kong starts a joint research project with leading HK university on cell sorting, encapsulation, and organ assembly with HK government grant ITF

May 12th, 2023 - Humacyte and Oberland Capital announce funding arrangement totaling up to $160 million

May 9th, 2023 - Humacyte announces publication in Lancet Regional Health - Europe presenting use of Human Acellular Vessel™ (HAV™) to treat vascular injuries in Ukraine

May 4th, 2023 - Humacyte's Human Acellular Vessel™ (HAV™) receives FDA's Regenerative Medicine Advanced Therapy (RMAT) designation for urgent arterial repair following vascular trauma

April 27th, 2023 - Humacyte, JDRF collaborating to develop insulin-producing biovascular pancreas to treat Type 1 Diabetes

April 19th, 2023 - uLab™ launches the orthodontics industry's first suite of practice-branded packing options

April 18th, 2023 - Humacyte announces publication of pre-clinical study comparing Human Acellular Vessel™ (HAV™) to expanded Polytetrafluoroethylene (ePTFE) graft in vascular trauma

April 11th, 2023 - Humacyte completes enrollment in Phase 3 trial of Human Acellular Vessel™ (HAV™) for hemodialysis access in end-stage renal diseases patients

April 6th, 2023 - Rege Nephro Selected as a J-Startup, a public-private startup support program

April 5th, 2023 - CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation

April 5th, 2023 - uLab™ and Mari's List further partner to maximize savings for mutual members

March 19th, 2023 - Convergence Biomanufacturing Ltd. participates in the 2023 National Biomanufacturing Academic Annual Conference and launches 1st generation of acoustic bio-assemblers in Beijing

March 9th, 2023 - uLab™ launches AI platform innovations and receives superior ratings for its uAssist™ treatment planning assistance service

February 24th, 2023 - Convergence Biomanufacturing Ltd. ranks first in "Science and Innovation China" Innovation and Entrepreneurship Investment Conference 2022

February 1st, 2023 - Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure

January 1st, 2023 - Convergence Biomanufacturing Ltd. launches world's first high-performance acoustic field bio-assembler

November 22nd, 2022 - uLab™ expands business opportunities as growth accelerates in clear aligner devices

September 21st, 2022 - uLab™ hires Jeffrey Lord as Senior Vice President of Sales, North America

August 25th, 2022 - Miromatrix Receives New Patent for Its Novel Perfusion Decellularization and Recellularization Technology

August 18th, 2022 - uLabs Systems™ ranked in the top 20% of fastest growing companies in America

August 9th, 2022 - u Assist™ Available for Orthodontists

July 1st, 2022 - Rege Nephro Announces Joint Research Agreement with CiRA, Kyoto University and Mitsui Chemicals Aiming to develop exosomes as a new modality (therapeutic method)

March 3rd, 2022 - uLab™ Completes $20M Financing from CareCapital

February 7th, 2022 - Rege Nephro Announces Joint Research Agreement with CiRA, Kyoto University and AstraZeneca

January 31st, 2022 - DMH participates in Rege Nephro Series A

May 26th, 2021 - uLab Systems™ to Launch uSmileTM Clear Aligners in Canada

January 12th, 2021 - Rege Nephro enters Joint Research Agreement with Nikkiso Co Ltd and ABI Co Ltd

Copyright 2004-2023 DM Healthcare

All Rights Reserved